Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-013864
Filing Date
2013-03-04
Accepted
2013-03-04 13:20:50
Documents
1
Period of Report
2013-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd372563.html 4  
1 FORM 4 rrd372563.xml 4 3882
  Complete submission text file 0001181431-13-013864.txt   5223
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 28TH STREET, SUITE 100 BOULDER CO 80301
Business Address
Hoerter Steven L. (Reporting) CIK: 0001533451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35347 | Film No.: 13660832